These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10889332)

  • 21. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
    Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E
    Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
    Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
    Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M
    Eur J Med Chem; 2001 Sep; 36(9):743-6. PubMed ID: 11672884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Click chemistry based regioselective one-pot synthesis of coumarin-3-yl-methyl-1,2,3-triazolyl-1,2,4-triazol-3(4H)-ones as newer potent antitubercular agents.
    Somagond SM; Kamble RR; Bayannavar PK; Shaikh SKJ; Joshi SD; Kumbar VM; Nesaragi AR; Kariduraganavar MY
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900013. PubMed ID: 31397503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
    Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
    J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
    Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles.
    Patel NB; Khan IH; Rajani SD
    Eur J Med Chem; 2010 Sep; 45(9):4293-9. PubMed ID: 20630629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional and microwave assisted synthesis of 2-oxo-4-substituted aryl-azetidine derivatives of benzotriazole: a new class of biological compounds.
    Dubey A; Srivastava SK; Srivastava SD
    Bioorg Med Chem Lett; 2011 Jan; 21(1):569-73. PubMed ID: 21130647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
    Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clubbed triazoles: a novel approach to antitubercular drugs.
    Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
    Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
    Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
    Zampieri D; Cateni F; Moneghini M; Zacchigna M; Laurini E; Marson D; De Logu A; Sanna A; Mamolo MG
    Curr Top Med Chem; 2019; 19(8):620-632. PubMed ID: 30827247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
    Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
    Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
    Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
    Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
    Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
    Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
    Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
    Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitubercular activity of 6-chloro (unsubstituted)- 2-methoxy-9-substituted acridine derivatives.
    Aly EI; Abadi AH
    Arch Pharm Res; 2004 Jul; 27(7):713-9. PubMed ID: 15356996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.